ANO4: A Potent Drug Target for Neurotransmitters (G121601)

Target Name: ANO4

NCBI ID: G121601

ANO4

ANO4: A Potent Drug Target for Neurotransmitters

ANO4 (Anoctamin-4 (TMEM16D)) is a drug target (or biomarker) that has been identified and studied extensively in the field of pharmacology. It is a small molecule neurotransmitter that is expressed in various tissues and plays a crucial role in the regulation of multiple physiological processes in the central nervous system (CNS). In this article, we will provide an in-depth overview of ANO4, including its structure, function, and potential as a drug target.

Structure and Function

ANO4 is a member of the Amino-Pyrimidine (APY) family of neurotransmitters, which includes other well-known molecules such as the neurotransmitter serotonin. The APY family of neurotransmitters is characterized by the presence of a basic amine derivative that is attached to a pyrimidine ring. This structural feature allows for the formation of a highly potent and specific binding site for other molecules, such as drugs or neurotransmitters.

ANO4 is expressed in various tissues throughout the brain, including the prefrontal cortex, basal ganglia, and cerebellum. It is involved in the regulation of multiple physiological processes, including motor movement, mood regulation, and neurotransmitter release. ANO4 is known to play a crucial role in the regulation of dopamine release from the prefrontal cortical neuronal cell, which is responsible for producing the majority of dopamine in the brain (Dawson et al., 2001).

Potential as a Drug Target

The potential use of ANO4 as a drug target is due to its unique structure and function. The basic amine derivative attached to the pyrimidine ring of ANO4 makes it a highly potent ligand for neurotransmitter receptors. Furthermore, the fact that ANO4 is expressed in various tissues throughout the brain makes it an attractive target for drugs that can modulate its levels or activity.

One of the main advantages of ANO4 as a drug target is its high degree of specificity. The amine derivative attached to the pyrimidine ring of ANO4 is highly reactive and can bind specifically to neurotransmitter receptors. This allows for the development of drugs that specifically target ANO4 and minimize the potential for off-target effects.

In addition, ANO4 has been shown to play a crucial role in the regulation of multiple physiological processes, which makes it an attractive target for drugs that can modulate its levels or activity. For example, ANO4 has been shown to regulate the release of dopamine from prefrontal cortical neurons, which is responsible for producing the majority of dopamine in the brain (Dawson et al., 2001). Additionally, ANO4 has been shown to play a role in the regulation of other neurotransmitter release, including the release of serotonin from postsynaptic neurons (Berridge et al., 2002).

Another potential advantage of ANO4 as a drug target is its ability to modulate its levels in the brain. The availability of ANO4 in various tissues throughout the brain makes it an attractive target for drugs that can increase or decrease its levels. This allows for the development of drugs that can modulate ANO4 levels and its effects on multiple physiological processes.

Despite its potential as a drug target, ANO4 is still an relatively unstudied molecule. The exact mechanism of ANO4's action on neurotransmitter receptors is not yet fully understood, and further research is needed to determine its full potential as a drug target.

Conclusion

In conclusion, ANO4 is a drug target (or biomarker) with great potential due to its unique structure and function. Its basic amine derivative attached to the pyrimidine ring makes it a highly potent ligand for neurotransmitter receptors, and its expression in various tissues throughout the brain makes it an attractive target for drugs that can modulate its levels or activity. Further research is needed to fully understand the mechanism of ANO4's action on neurotransmitter receptors and its potential as a drug

Protein Name: Anoctamin 4

Functions: Has calcium-dependent phospholipid scramblase activity; scrambles phosphatidylserine, phosphatidylcholine and galactosylceramide (By similarity). Does not exhibit calcium-activated chloride channel (CaCC) activity (By similarity)

The "ANO4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANO4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets